Publication | Open Access

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Hematological MalignancyCell TherapyMalignant Blood DisorderHematologyImmunologyAutoimmunityAdoptive Cell TherapyCell TransplantationAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyNatural Killer Cells